2 research outputs found
A Comparative Study of Disordered and Ordered Protein Folding Dynamics Using Computational Simulation
Folding protein dynamics has been an area of high interest for quite some
time, especially given the increased focus on the field of Biophysics. Because
folding dynamics occur on such short time scales, empirical techniques
developed for more "static" protein events, such as X-ray crystallography,
nuclear magnetic resonance, and green fluorescent protein (GFP) labelling,
aren't as applicable. Instead, computational methods must often be used to
simulate these short lived yet highly dynamic events. One such computational
method that is proven to provide much valuable insight into protein folding
dynamics is Molecular Dynamics Simulation (MD Simulation). This simulation
method is both highly computationally demanding, yet highly accurate in its
modelling of a proteins physical behaviour. Besides MD Simulation, simulations
in general are quite applicable in the context of these protein events. For
example, the simple Gillespie algorithm, a computational technique which can be
executed on almost any personal computer, provides quite the robust view into
protein dynamics given its computational simplicity. This paper will compare
the results of two simulations, an MD simulation of a disordered, six-residue,
carcinogenic protein fragment, and a Gillespie algorithm based simulation of an
ordered folding protein: the mathematically identical nature of the Gillespie
algorithm time series of the asymptotically stochastic hyperbolic tangent
dynamics for the wild type predicting the exact behaviour of the carcinogenic
protein system time series will show the computational power simulations
provide for analyzing both disordered and ordered protein systems.Comment: 13 pages, draft 1, 8 figure
The Concurrent Use of Medical Imaging Modalities and Innovative Treatments to Combat Retinitis Pigmentosa
Retinitis pigmentosa (RP), one of the leading causes of vision loss and
blindness globally, is a progressive retinal disease involving the degradation
of photoreceptors (7) and/or retinal pigment epithelial cells (14). Affecting
approximately 1 in 4000 people, RP is caused by a series of genetic mutations;
each specific mutation presents a specific pathological pattern in the patient,
with the same mutation even presenting in different phenotypes in different
patients (14). RP generally starts with peripheral vision loss, attacking the
rods first, causing nyctalopia or night blindness (22). In later stages of the
disease, the cones start to atrophy, further narrowing the field of vision and
obscuring central vision (22). Luckily, with recent advances in medical imaging
techniques and novel therapeutic treatments, both early detection and the
overall prognosis of RP in patients have improved dramatically in the past few
decades. This review will trace RP's physiological causes, how it affects
retinal and ocular physiology, the techniques through which we can diagnose and
image it, and the various treatments developed to try to combat it. The medical
imaging techniques to be discussed include but are not limited to adaptive
optics (AO), OCT including SD-OCT and OCTA, fundus autofluorescence (FAF) and
its associated fluorescence lifetime imaging ophthalmoscopy (FLIO), colour
Doppler flow imaging (CDFI), microperimetry, and MRI. The treatments to be
discussed include stem cell therapy, gene therapy, cell transplantation,
pharmacological therapy, and artificial retinal implants. Throughout this
review, it will be made evident of not just the severity and diversity through
which RP can present, but also the advanced made in medical imaging and
innovative treatments designed to combat this pathology.Comment: 39 pages, 23 figure